Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Cameron

Showing results (831-840 of 1,032) with videos related to

Pageof 104
Sort By:
Human Reproduction (Oxford, England)|September 28, 2002
Improving cycle control in progestogen-only contraceptive pill users by intermittent treatment with a new anti-progestogenK Gemzell-Danielsson, A M van Heusden, S R Killick, et al.
Clinical Nephrology|August 1, 1978
Focal segmental glomerulosclerosis with rapid decline in renal function ("malignant FSGS")C B Brown, J S Cameron, D R Turner, et al.
The Quarterly Journal of Medicine|January 1, 1983
Late onset systemic lupus erythematosus and lupus-like disease in patients with apparent idiopathic glomerulonephritisD Adu, D G Williams, D Taube, et al.
The Quarterly Journal of Medicine|January 1, 1979
Systemic lupus with nephritis: a long-term studyJ S Cameron, D R Turner, C S Ogg, et al.
Clinical and Experimental Immunology|July 1, 1972
Complement studies in membrano-proliferative glomerulonephritisD K Peters, A Martin, A Weinstein, et al.
The Journal of Infection|June 7, 2000
Prevalence of hepatitis C virus infection among injecting drug users in Glasgow 1990-1996: are current harm reduction strategies working?A Taylor, D Goldberg, S Hutchinson, et al.
Journal of Pediatric Gastroenterology and Nutrition|August 23, 2002
Celiac disease: Working Group Report of the First World Congress of Pediatric Gastroenterology, Hepatology, and NutritionIvor D Hill, Shinjini Bhatnagar, Donald J S Cameron, et al.
Journal of the American Academy of Dermatology|September 23, 2014
A 52-week, open-label study of the efficacy and safety of ixekizumab, an anti-interleukin-17A monoclonal antibody, in patients with chronic plaque psoriasisKenneth B Gordon, Craig L Leonardi, Mark Lebwohl, et al.
Journal of Viral Hepatitis|October 23, 2010
The influence of hepatitis C and alcohol on liver-related morbidity and mortality in Glasgow's injecting drug user populationS A McDonald, S J Hutchinson, P R Mills, et al.
Archives of Disease in Childhood|June 1, 1980
10 years' experience with regular haemodialysis and renal transplantationC Chantler, J E Carter, M Bewick, et al.
Pageof 104

Showing results (831-840 of 1,032) with videos related to

Sort By:
Pageof 104
Human Reproduction (Oxford, England)|September 28, 2002
Improving cycle control in progestogen-only contraceptive pill users by intermittent treatment with a new anti-progestogenK Gemzell-Danielsson, A M van Heusden, S R Killick, et al.
Clinical Nephrology|August 1, 1978
Focal segmental glomerulosclerosis with rapid decline in renal function ("malignant FSGS")C B Brown, J S Cameron, D R Turner, et al.
The Quarterly Journal of Medicine|January 1, 1983
Late onset systemic lupus erythematosus and lupus-like disease in patients with apparent idiopathic glomerulonephritisD Adu, D G Williams, D Taube, et al.
The Quarterly Journal of Medicine|January 1, 1979
Systemic lupus with nephritis: a long-term studyJ S Cameron, D R Turner, C S Ogg, et al.
Clinical and Experimental Immunology|July 1, 1972
Complement studies in membrano-proliferative glomerulonephritisD K Peters, A Martin, A Weinstein, et al.
The Journal of Infection|June 7, 2000
Prevalence of hepatitis C virus infection among injecting drug users in Glasgow 1990-1996: are current harm reduction strategies working?A Taylor, D Goldberg, S Hutchinson, et al.
Journal of Pediatric Gastroenterology and Nutrition|August 23, 2002
Celiac disease: Working Group Report of the First World Congress of Pediatric Gastroenterology, Hepatology, and NutritionIvor D Hill, Shinjini Bhatnagar, Donald J S Cameron, et al.
Journal of the American Academy of Dermatology|September 23, 2014
A 52-week, open-label study of the efficacy and safety of ixekizumab, an anti-interleukin-17A monoclonal antibody, in patients with chronic plaque psoriasisKenneth B Gordon, Craig L Leonardi, Mark Lebwohl, et al.
Journal of Viral Hepatitis|October 23, 2010
The influence of hepatitis C and alcohol on liver-related morbidity and mortality in Glasgow's injecting drug user populationS A McDonald, S J Hutchinson, P R Mills, et al.
Archives of Disease in Childhood|June 1, 1980
10 years' experience with regular haemodialysis and renal transplantationC Chantler, J E Carter, M Bewick, et al.
Pageof 104